26TH PAN-AMERICAN CONGRESS OF RHEUMATOLOGY 
-REGULATIONS FOR THE SUBMISSION OF PAPERS-. 

1. DEADLINE: 

The deadline for submission of papers will be December 14th, 2023, 6:00 p.m. Barranquilla, Colombia. No extension is possible. 
All papers for the 26th Pan American Congress of Rheumatology shall be submitted electronically through the system that will be enabled for this purpose. Papers cannot be sent by fax, hard copy or  email. 

2. REGISTRATION: 

You may submit your paper without being registered. The Presenting Author  should be registered in order to present during the conference. 
If the paper is accepted, the Presenting Author will have access to the Early Bird Rate until  February 28, 2024 to register for the conference. 

3. PUBLICATION: 

Accepted papers will be published in the PANLAR Global Rheumatology journal. 

4. ABSTRACT LIMIT: 

There are no restrictions on the number of abstracts an author may submit or  present at the Congress. 

5. LANGUAGE: 

Abstracts shall be written in English. Tables, figures and abbreviations must be  in English. Abstracts not in English will not be evaluated. 
If you are not fluent in English, seek assistance in writing your abstract. Poor drafting in English will be  grounds for disapproval. 
PPTs (for oral presentations) and posters shall be in English. The Oral Presentation at the congress may  be given in Spanish, Portuguese or English. 

6. CHARACTERISTICS: 

Use clear language, avoiding complex characters or formulas. Abstracts should be structured as: Background / Objective, Methods, Results, Conclusion. 

7. CHARACTER LIMIT: 

The limit is 2,500 characters for the text of your abstract and references,  including spaces and punctuation (this does not include author information, title or keywords). 
You may include 1 image and 1 table; or 2 images, or 2 tables. Figures, tables and images included  in the abstract must be referenced in the text. Tables should be created with the corresponding tool  in the form, and should not be uploaded as an image. 

8. EVALUATION: 

To preserve the peer review process, do not include any information (e.g., authors'  names or institutions) in the body of your paper. 

9. REFERENCES: 

These are not mandatory (their use is discouraged). In the exceptional case of using  them, the limit is two (2), adopting the standard format set by the publication (Global Rheumatology). 

10. CITATIONS: 

Should strictly comply with Vancouver standards, and are to be numbered consecutively  according to the order of appearance in the text, in Arabic numerals in parentheses and not as superscript  or subscript. Example:  
Name of Author(s), Title of article. Title of the journal or book. Volume, number, year, Pages. Available  at: URL.

11. FOLLOW THE INSTRUCTIONS ON SCREEN to access the paper submission form. Complete  all fields on the form. 

12. STATEMENT: 

The system will prompt the submitter to complete a statement of relevant funding  sources to finalize the submission. 

13. PRESENTATION TYPE: 

You must select a preferred presentation type (Oral or Poster) and the  corresponding topic from the following options: 

1. Basic science 
2. Crystal arthropathy 
3. Epidemiology (including socioeconomic, socio-cultural and gender equity studies) 
4. Fibromyalgia and pain 
5. Imaging 
6. Infections (including COVID-19) 
7. Osteoarthritis 
8. Osteoporosis 
9. Pediatric Rheumatology 
10. Psoriatic arthritis 
11. Rheumatoid arthritis 
12. Rheumatology education 
13. Sjogren's and other systemic autoimmune diseases 
14. Spondyloarthritis 
15. Systemic Lupus Erythematosus 
16. Vasculitis and related diseases 
17. Miscellaneous 

The decision on the type of presentation will be made by the Evaluation Committee. 

14. AUTHORS: 

Please enter the names of the authors in the order in which they should appear in the  paper header. 
It is the responsibility of the submitter to write correctly the full names of the other authors,  which will be reproduced on the certificate as submitted (if accepted). 
Confirmation of receipt of the paper will be sent to the e-mail address given in the paper. 
The contact author will receive all notifications related to the paper and will be responsible for informing  the co-authors of its status. 

15. REVIEW OF YOUR ABSTRACT: 

Check your paper carefully. Make sure that all special characters  and formatting look correct on your final proof. If you find errors, return to the appropriate page to  correct them. It is the author's responsibility to submit the paper correctly. 

16. FINAL SUBMISSION: 

Once all fields have been completed, papers may be saved in "Final  Submission" status. Only abstracts saved in "Final Submission" will be considered as  successfully submitted and considered for the Congress. Papers submitted or saved as in progress  or drafts cannot be edited after the submission deadline. 
CANCELLED papers will not be considered for evaluation. 

17. NOTIFICATIONS: 

Will be sent by email by mid-February 2024.
The decision of the Evaluation Committee will be irrevocable and there will be no instances of review  of the evaluation. 

18. PRESENTATION: 

For accepted abstracts it is mandatory that the presenting author presents the  paper during the day and time assigned at the Congress. 

19. CERTIFICATE: 

Only one certificate per paper will be issued, which will include all authors in the  order in which they were submitted. 

20. TECHNICAL ASSISTANCE: 

If you have any difficulty during the submission process, please contact  scientific-secretariat@wearemci.com. 

21. Papers previously presented at other conferences: 

May be accepted at PANLAR 2024 as long as the  copyright of the other event, conference or congress is not infringed. Authors are strongly encouraged  to add new data generated between the previous presentation and the PANLAR 2024 abstract  submission deadline. If your abstract has been previously presented at another conference, it will only  be considered for poster presentation by the organizing committee. 

If the paper has been previously presented at another conference, it should be indicated in the  corresponding section.